This Cancer Drug Is So Effective, The FDA Approved It Immediately
June 11, 2017
A new cancer drug has overwhelmingly helped shrink or eradicate tumors in patients whose cancer had resisted every other form of treatment.
The results, published in the journal Science, are so striking that the Food and Drug Administration already has approved the drug.

Image credit: Merck
The study followed 86 cancer patients with tumors of the pancreas, prostate, uterus or bone. Each patient was given pembrolizumab, which also goes by the brand name Keytruda.
After taking the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned.
According to the New York Times, this is the first time a drug has been approved for use against tumors that share a particular genetic profile, regardless of where they appear in the body.
Dr. Jack Jacoub, a medical oncologist and director of thoracic oncology at Memorial Care Cancer Institute at Orange Coast Memorial Medical Center, said "The FDA doesn't take these kinds of things lightly. The data was so good, they had to approve it."
His Last Day As A Teacher After 36 Years. They Turned It Into A Memory For Life
'I Laughed And Cried': Vet’s Hilarious Condolence Card Brings Laughter To Grieving Cat Owner
Three Brothers Cleaning Out Mom’s Attic Found A Comic Worth $9 Million
Teen Runs His Own Restaurant ALONE — One Of The Most Uplifting Stories You'll Read
Pet Owners Share Hilarious Stories Of Paying The Vet… Just To Find Out Their Pets Are Weird
A Man Ruined A Beautiful Snowman Display — What Happened Next Was Perfect
A Stray Dog Wouldn't Let Go Of A Toy, So Shoppers Bought It For Him
Daycare Worker Goes Viral After Dancing For Babies — Their Reactions Are Priceless
Unexpected Friends: Rhino And Tiny Deer Play In Snow
Sheep Escape Herd And Wander Into Supermarket In Funny Video
Dog And Rooster Chase Each Other In The Funniest Video You’ll See Today
